ArticleAntibody therapeutics2026

Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates.

Aiko Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.